Opportunity Information: Apply for RFA GH 13 004
Apply for RFA GH 13 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Surveillance for Japanese Encephalitis in India" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Apr 21, 2015 and posted on Dec 17, 2012.
- Applicants must submit their applications by May 21, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible OrganizationsNational Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, IndiaForeign OrganizationsForeign Organizations are eligible to apply. Foreign components of U.S. Organizations are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening Surveillance for Japanese Encephalitis in India" (Funding Opportunity Number RFA GH 13 004) is a U.S. Centers for Disease Control and Prevention (CDC) discretionary funding announcement intended to support the CDC Global Disease Detection (GDD) Program in India. Its core aim is to improve and expand public health surveillance for Japanese Encephalitis (JE), a mosquito-borne viral disease that can cause severe neurologic illness and outbreaks in parts of Asia, including India. In practical terms, the opportunity is focused on strengthening the systems that detect, track, and characterize JE cases so that public health officials can better understand disease burden, identify hotspots, detect outbreaks earlier, and guide prevention and control measures.
This funding is offered as a cooperative agreement, which generally means the recipient is expected to work closely with CDC staff, with substantial involvement from the agency in planning, implementation, and technical direction compared with a standard grant. The program falls under the health activity category and is associated with CFDA number 93.283 (CDC Investigations and Technical Assistance). The announcement anticipated making one award, indicating that CDC likely intended to support a single major implementing partner to carry out the work in coordination with the GDD program.
Financially, the announcement lists an estimated total funding amount of $10,000,000, while also stating an award ceiling of $500,000 and an award floor of $0. These figures suggest that the broader funding context may span multiple years, phases, or related activities, while the specific award amount for an individual budget period could be capped at $500,000; however, without the full program announcement narrative, the exact relationship among these numbers (for example, whether the $10 million reflects cumulative or program-wide estimates) cannot be fully confirmed from the excerpt alone. Importantly, the opportunity does not require cost sharing or matching funds, so applicants were not obligated to contribute non-federal funds as a condition of receiving the award.
Eligibility was relatively specific. The named eligible organization is the National Institute of Mental Health and Neuro Sciences (NIMHANS) in Bangalore, India, and the announcement also indicates that foreign organizations are eligible to apply. Additionally, foreign components of U.S. organizations are eligible. The eligibility line "Others (see text field entitled Additional Information on Eligibility for clarification)" suggests there were likely more detailed eligibility rules in the full announcement, but based on the information provided here, the key takeaway is that this opportunity was designed with a strong expectation of implementation capacity in India and the ability to partner effectively with CDC in-country surveillance strengthening.
The timeline information shows the opportunity was posted on December 17, 2012, with an original closing date of April 4, 2013, and a later current closing date of May 21, 2015. It was archived on May 23, 2015. That pattern typically reflects an announcement that may have been re-opened, amended, extended, or otherwise administratively updated after the initial closing date, though the excerpt does not specify why. The creation date listed (April 21, 2015) aligns with the later administrative activity and may reflect when the record was re-entered or updated in a system rather than the first publication date.
For applicants needing assistance accessing the full announcement, the contact point is the CDC Procurement and Grants Office Technical Information Management team, reachable by telephone at (770) 488-2700 or by email at pgotim@cdc.gov. Overall, the opportunity is best understood as a targeted CDC-supported effort to improve JE surveillance capacity in India through a close, cooperative partnership, with the ultimate public health goal of better situational awareness and faster, more effective response to JE risk and transmission.
FAQs: Strengthening Surveillance for Japanese Encephalitis in India (RFA GH 13 004)
What is the title of this funding opportunity?
The funding opportunity is titled "Strengthening Surveillance for Japanese Encephalitis in India."
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is RFA GH 13 004.
Which U.S. agency is offering this grant opportunity?
This is a U.S. Centers for Disease Control and Prevention (CDC) discretionary funding announcement.
What CDC program is this opportunity intended to support?
The opportunity is intended to support the CDC Global Disease Detection (GDD) Program in India.
What public health issue does this opportunity focus on?
It focuses on Japanese Encephalitis (JE), a mosquito-borne viral disease that can cause severe neurologic illness and outbreaks in parts of Asia, including India.
What is the main purpose of the funding?
The core aim is to improve and expand public health surveillance for Japanese Encephalitis in India, strengthening the systems used to detect, track, and characterize JE cases.
What kinds of outcomes is the program trying to enable through better surveillance?
Based on the description provided, improved surveillance is intended to help public health officials better understand disease burden, identify hotspots, detect outbreaks earlier, and guide prevention and control measures.
What type of award mechanism is being used?
The funding is offered as a cooperative agreement.
What does it mean that this is a cooperative agreement?
In this announcement, a cooperative agreement indicates the recipient is expected to work closely with CDC staff, with substantial CDC involvement in planning, implementation, and technical direction compared with a standard grant.
What activity category does this opportunity fall under?
The program falls under the health activity category.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.283 (CDC Investigations and Technical Assistance).
How many awards did CDC anticipate making?
The announcement anticipated making one award.
What is the estimated total funding amount listed?
The announcement lists an estimated total funding amount of $10,000,000.
What is the award ceiling (maximum) mentioned in the excerpt?
The award ceiling listed is $500,000.
What is the award floor (minimum) mentioned in the excerpt?
The award floor listed is $0.
How should applicants interpret the $10,000,000 estimated total funding versus the $500,000 award ceiling?
From the excerpt alone, the exact relationship among these numbers cannot be fully confirmed. The description suggests the broader funding context may span multiple years, phases, or related activities, while the specific award amount for an individual budget period could be capped at $500,000.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching funds, so applicants were not obligated to contribute non-federal funds as a condition of receiving the award.
Who is explicitly named as an eligible organization?
The named eligible organization is the National Institute of Mental Health and Neuro Sciences (NIMHANS) in Bangalore, India.
Are foreign organizations eligible to apply?
Yes. The announcement indicates that foreign organizations are eligible to apply.
Are foreign components of U.S. organizations eligible?
Yes. The announcement states that foreign components of U.S. organizations are eligible.
Does the eligibility section suggest there may be additional rules?
Yes. The eligibility line includes "Others (see text field entitled Additional Information on Eligibility for clarification)," which suggests there were likely more detailed eligibility requirements in the full announcement. The excerpt does not provide those details.
When was the opportunity posted?
The opportunity was posted on December 17, 2012.
What was the original closing date?
The original closing date was April 4, 2013.
What was the later/current closing date shown in the record?
The later current closing date shown is May 21, 2015.
When was the opportunity archived?
It was archived on May 23, 2015.
Why do the dates show an original closing date and a later closing date?
The excerpt indicates a pattern that typically reflects an announcement that may have been re-opened, amended, extended, or otherwise administratively updated after the initial closing date. The excerpt does not specify the exact reason.
What does the creation date (April 21, 2015) likely indicate?
Based on the information provided, the creation date aligns with later administrative activity and may reflect when the record was re-entered or updated in a system rather than the first publication date.
Who should applicants contact for help accessing the full announcement?
Applicants needing assistance accessing the full announcement can contact the CDC Procurement and Grants Office Technical Information Management team.
What is the contact phone number for the CDC Procurement and Grants Office Technical Information Management team?
The phone number is (770) 488-2700.
What is the contact email for the CDC Procurement and Grants Office Technical Information Management team?
The email address is pgotim@cdc.gov.
In plain terms, what is this opportunity best understood as?
It is a targeted CDC-supported effort to improve Japanese Encephalitis surveillance capacity in India through a close, cooperative partnership, with the overall goal of better situational awareness and faster, more effective response to JE risk and transmission.
Browse more opportunities from the same category: Health
Next opportunity: AHRQ Health Services Research Projects (R01)
Previous opportunity: RESEARCH OPPORTUNITIES IN COMPLEX FLUIDS AND MACROMOLECULAR BIOPHYSICS
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH 13 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH 13 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| AHRQ Health Services Research Projects (R01) Apply for PA 13 045 Funding Number: PA 13 045 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| AHRQ Health Services Research Demonstration and Dissemination Grants (R18) Apply for PA 13 046 Funding Number: PA 13 046 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| Detecting etiologies of emerging infectious diseases at the regional level Western Ghat Region of Karnataka and Kerala, India Apply for RFA GH 13 003 Funding Number: RFA GH 13 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30) Apply for RFA OD 12 007 Funding Number: RFA OD 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region Apply for RFA GH 13 001 Funding Number: RFA GH 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,000,000 |
| Monitoring and Evaluation of Malaria Control and Elimination Activities Apply for RFA GH 13 005 Funding Number: RFA GH 13 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Prevalence and Incidence of Inflammatory Bowel Disease Apply for RFA DP 13 001 Funding Number: RFA DP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| NIDCD Small Grant Program (R03) Apply for PAR 13 057 Funding Number: PAR 13 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Estimating the Costs of Supporting Primary Care Practice Transformation (R03) Apply for RFA HS 13 003 Funding Number: RFA HS 13 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| Strengthening Public Health and the Public Health Laboratory System of Cambodia under the Presidents Emergency Plan for AIDS Relief Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1305 Funding Number: CDC RFA GH13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantees Apply for HRSA 13 152 Funding Number: HRSA 13 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| R40 MCH Autism Intervention Research Apply for HRSA 13 195 Funding Number: HRSA 13 195 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the Presidents Em Apply for CDC RFA GH13 1303 Funding Number: CDC RFA GH13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Global Animal Human Interface Activities for Avian Influenza and other Zoonotic Diseases Apply for RFA CK 13 002 Funding Number: RFA CK 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region Apply for RFA IP 13 002 Funding Number: RFA IP 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142 Funding Number: HRSA 13 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304 Funding Number: CDC RFA GH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062 Funding Number: PAR 13 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001 Funding Number: CMS 1A1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065 Funding Number: PAR 13 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 13 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.